Management of hepatitis B reactivation in immunosuppressed patients: An update on current recommendations

Table 1 Diagnostic tools suggested for hepatitis B screening prior to immunosuppression therapy by different major guidelines

Recommendations	Hepatitis B screening tests before immunosuppression
	HBsAg	AntiHBc	HBV DNA	AntiHBs
CDC	Yes	Yes	No	Yes
AASLD	High risk	High risk	No	No
EASL	Yes	Yes	No	No
APASL	Yes	No	No	No
ASCO	High risk	High risk	No	Yes1

¹Only suggested in antiHBc-positive patients. CDC: Center for Disease Control; AASLD: American Association for the Study of Liver Disease; EASL: European Association for the Study of the Liver; APASL: Asian Pacific Association for the Study of the Liver; ASCO: American Society Clinical Oncology; HBV: Hepatitis B virus; HBsAg: Hepatitis B surface antigen; AntiHBc: Antibody to hepatitis B core antigen; AntiHBs: Antibody to hepatitis B surface antigen.